2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1851374755 MD
Verify on CMS →

STEVEN HALASZ, MD

Endocrinology, Diabetes & Metabolism Physician in PORT CHARLOTTE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 530 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$42.7
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEVEN HALASZ, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 7,104 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
7K
Part D claims, 2023
81%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEVEN HALASZ, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEVEN HALASZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEVEN HALASZ, MD?

Below national average

NPI registry status

Active

Issued 11/23/2005

NPI 1851374755

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

7,104 169% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

STEVEN HALASZ, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEVEN HALASZ, MD is a Endocrinology, Diabetes & Metabolism Physician provider practicing in PORT CHARLOTTE, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1851374755. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

STEVEN HALASZ, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 4369 TAMIAMI TRL, PORT CHARLOTTE, FL, 33980, with a listed phone of (941) 629-3366. NPI 1851374755 was issued on 11/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HALASZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,104 prescription claims written by this provider, covering 530 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 19% brand-name and 81% generic by claim count, with an opioid prescribing rate of 0.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4369 TAMIAMI TRL
PORT CHARLOTTE, FL 33980

Provider Details

NPI 1851374755
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 11/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where STEVEN HALASZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LEGACY HEALTHCARE SERVICES INC
ENGLEWOOD, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEVEN HALASZ, MD. Source: openpaymentsdata.cms.gov.

Total received

$43

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to STEVEN HALASZ, MD. To verify STEVEN HALASZ, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

STEVEN HALASZ, MD — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 7,104 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,104
Total Claims
$1.1M
Total Drug Cost
530
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
18,942
Total Day Supply
559,230
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$947K
Generic Drug Cost
$115K
Opioid Claims
22 (0.3% rate)
Antibiotic Claims
211

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.29
Gender Split
52% female / 48% male
Age Distribution
<65: 34, 65-74: 240, 75-84: 199, 85+: 57

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
738
Rosuvastatin Calcium
517
Lisinopril
332
Amlodipine Besylate
305
Atorvastatin Calcium
274
Metformin Hcl
251
Synthroid
Levothyroxine Sodium
134
Simvastatin
126
Metoprolol Tartrate
119
Omeprazole
119

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How STEVEN HALASZ, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

STEVEN HALASZ, MD's 7,104 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as HALASZ.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEVEN HALASZ, MD's specialty?
STEVEN HALASZ, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in PORT CHARLOTTE, Florida. Credentials: MD.
How much does STEVEN HALASZ, MD prescribe under Medicare Part D?
In 2023, STEVEN HALASZ, MD wrote 7,104 Medicare Part D claims totaling $1.1M in drug costs for 530 beneficiaries.
What is STEVEN HALASZ, MD's Medicare quality score?
STEVEN HALASZ, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEVEN HALASZ, MD located?
STEVEN HALASZ, MD is located at 4369 TAMIAMI TRL, PORT CHARLOTTE, FL, 33980. Phone: (941) 629-3366.
What is STEVEN HALASZ, MD's NPI number?
STEVEN HALASZ, MD's National Provider Identifier (NPI) is 1851374755, issued on 11/23/2005.
Does STEVEN HALASZ, MD prescribe more brand-name or generic drugs?
STEVEN HALASZ, MD's prescribing is 19% brand-name and 81% generic drugs by claim count, with $947K in brand drug costs.
Does STEVEN HALASZ, MD prescribe opioids?
Yes, STEVEN HALASZ, MD had 22 opioid claims in 2023 with an opioid prescribing rate of 0.3%.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does STEVEN HALASZ, MD prescribe most often?
Based on 2023 Medicare Part D data, STEVEN HALASZ, MD's most frequently prescribed drugs include Levothyroxine Sodium, Rosuvastatin Calcium, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEVEN HALASZ, MD accept Medicare?
STEVEN HALASZ, MD appears in CMS Medicare data with 7,104 Part D claims and 530 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEVEN HALASZ, MD's credentials?
STEVEN HALASZ, MD's NPI is 1851374755 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology